Just heard on the news , 2017-2018. , 2.2% drop in cancer dead I USA , this is mostly because of early detection and better treatment in Malignant Melanoma and lung cancer ..

In Europe statistics not as good since there is limitation in treatment ..

With all the improvement we see in USA still more cases and death in breast , colorectal and prostate cancer .

Hopefully with help of Leronlimab statistics with those cancers will also improve very soon ..

Let’s get some more patients and approval within months and not years !!